Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumors

Frontiers in Oncology

Volumn 3 SEP, Issue , 2013, Pages

  Cherkasova, Elena ^a   Weisman, Quinn ^a   Childs, Richard W ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Antigen; Cancer treatment; Cytotoxic T cells; Human endogenous retroviruses; Immunotherapy

Indexed keywords

GAG PROTEIN; HYPOXIA INDUCIBLE FACTOR; PROTEIN MYB; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSCRIPTION FACTOR YY1; VON HIPPEL LINDAU PROTEIN;

ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOGENOUS RETROVIRUS; HUMAN; KIDNEY CANCER; NONHUMAN; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR IMMUNITY; VIRUS REACTIVATION;

EID: 84891062461     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00243     Document Type: Article

References (43)

1. Stroncek DF, Berger C, Cheever MA, Childs RW, Dudley ME, Flynn P, et al. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer. J Transl Med (2012) 10:48-53. doi:10.1186/1479-5876-10-48
2. Morgan R, Dudley M, Wunderlich J, Hughes M, Yang J, Sherry R, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science (2006) 314:126-9. doi:10.1126/science.1129003
3. Johnson L, Morgan R, Dudley M, Cassard L, Yang J, Hughes M, et al. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood (2009) 114:535-46. doi:10.1182/blood-2009-03-211714
4. Muster T, Waltenberger A, Grassauer A, Hirschl S, Caucig P, Romirer I, et al. An endogenous retrovirus derived from human melanoma cells. Cancer Res (2003) 63:8735-41.
5. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res (2006) 65:4172-80. doi:10.1158/0008-5472.CAN-04-2983
6. Serafino A, Balestrieri E, Pierimarchi P, Matteucci C, Moroni G, Oricchio E, et al. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp Cell Res (2009) 315:849-62. doi:10.1016/j.yexcr.2008.12.023
7. Wang-Johanning F, Frost A, Jian B, Epp L, Lu D, Johanning G. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene (2003) 22:1528-35. doi:10.1038/sj.onc.1206241
8. Wang-Johanning F, Frost A, Jian B, Azuero R, Lu D, Chen D, et al. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer (2003) 98:187-97. doi:10.1002/cncr.11451
9. Menendez L, Benigno B, McDonald J. LI and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas. Mol Cancer (2004) 3:12-7. doi:10.1186/1476-4598-3-12
10. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen D, et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer (2006) 120:81-90. doi:10.1002/ijc.22256
11. Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy J, et al. Regression of kidney cancer following allogeneic stem-cell transplantation associated with T-cells recognizing a HERV-E antigen. J Clin Invest (2008) 118:1099-109. doi:10.1172/JCI34409C1
12. Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko V, Kudryavtseva A, et al. Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene (2011) 30:4697-706. doi:10.1038/onc.2011.179
13. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med (2000) 343:750-8. doi:10.1056/NEJM200009143431101
14. Bregni M, Dodero A, Peccatori J, Pescarollo A, Bernardi M, Sassi I, et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood (2002) 99:4234-6. doi:10.1182/blood.V99.11.4234
15. Cherkasova E, Weisman Q, Harashima N, Kagigaya S, Takahashi Y, Reger R, et al. Identification of a human endogenous retrovirus type-E (HERV-E) envelope with selective expression in clear cell kidney cancer that is immunogenic in vitro. Blood (2012) 120:3015.
16. Walsh CP, Chaillet JR, Bestor TH. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat Genet (1998) 20:116-7. doi:10.1038/2413
17. Costello JF, Plass C. Methylation matters. J Med Genet (2001) 38:285-303. doi:10.1136/jmg.38.5.285
18. Gotzinger N, Sauter M, Roemer K, Mueller-Lantzsch N. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. J Gen Virol (1996) 77:2983-90. doi:10.1099/0022-1317-77-12-2983
19. Lavie L, Kitova M, Maldener E, Meese E, Mayer J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K (HML-2). J Virol (2005) 79:876-83. doi:10.1128/JVI.79.2.876-883.2005
20. Wentzensen N, Coy J, Knaebel H, Linnebacher M, Wilz B, Gebert J, et al. Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers. Int J Cancer (2007) 121:1417-23. doi:10.1002/ijc.22826
21. Szpakowski S, Sun X, Lage M, Dyer A, Rubinstein J, Kowalski D, et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene (2009) 448:151-67. doi:10.1016/j.gene.2009.08.006
22. Stengel S, Fiebig U, Kurth R, Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer (2010) 49:401-11. doi:10.1002/gcc.20751
23. Sjottem E, Anderssen S, Johansen T. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 30 to the TATA box. J Virol (1996) 70:188-98.
24. de Parseval N, Alkabbani H, Heidmann T. The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol (1999) 80:841-5.
25. Knossl M, Lower R, Lower J. Expression of the human endogenous retrovirus HTDV/HERV-K is enhanced by cellular transcription factor YY1. J Virol (1999) 73:1254-61.
26. Fuchs NV, Kraft M, Tondera C, Hanschmann K, Lower J, Lower R. Expression of the human endogenous retrovirus group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by the transcription factors Sp1 and Sp3. J Virol (2011) 85:3436-48. doi:10.1128/JVI.02539-10
27. Katoh I, Mirova A, Kurata S, Murakami Y, Horikawa K, Nakakuki N, et al. Activation of the long terminal repeat of human endogenous retrovirus K by melanoma-specific transcription factor MITF-M. Neoplasia (2011) 13:1081-92.
28. Montel V, Suzuki M, Galloy C, Mose E, Tarin D. Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation (2009) 78:283-91. doi:10.1016/j.diff.2009.07.007
29. Kaelin WG. Treatment of kidney cancer: insights provided by the VHL tumor-suppressor protein. Cancer (2009) 115:2262-72. doi:10.1002/cncr.24232
30. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd K, Lenz J. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol (1999) 9:861-8. doi:10.1016/S0960-9822(99)80390-X
31. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet (1999) 21:257-8. doi:10.1038/6766
32. Reus K, Mayer J, Sauter M, Scherer D, Muller-Lantzsch N, Meese E. Genomic organization of the human endogenous retrovirus HERV-K (HML-2.HOM) (ERVK6) on chromosome 7. Genomics (2001) 72:314-20. doi:10.1006/geno.2000.6488
33. Sauter M, Schommer S, Kremmer E, Remberger K, Dölken G, Lemm I, et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol (1995) 69:414-21.
34. Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, et al. Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res (1996) 56:4362-5.
35. Humer J, Waltenberger A, Grassauer A, Kurz M, Valencak J, Rapberger R, et al. Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses. Cancer Res (2006) 66:1658-63. doi:10.1158/0008-5472.CAN-05-2452
36. Hahn S, Ugurel S, Hanschmann K, Strobel H, Tondera C, Schadendorf D, et al. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses (2008) 24:717-23. doi:10.1089/aid.2007.0286
37. Golan M, Hizi A, Resau J, Yaal-Hahoshen N, Reichman H, Keydar I, et al. Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia (2008) 10:521-33.
38. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer J, Yan P, Sastry K, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res (2008) 68:5869-77. doi:10.1158/0008-5472.CAN-07-6838
39. Zhao J, Rycaj K, Geng S, Li M, Plummer J, Yin B, et al. Expression of human endogenous retrovirus type K envelope protein is a novel candidate prognostic marker for human breast cancer. Genes Cancer (2011) 9:914-22. doi:10.1177/1947601911431841
40. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, et al. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst (2012) 104:189-210. doi:10.1093/jnci/djr540
41. Schiavetti F, Thonnard J, Colau D, Boon T, Coulie P. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res (2002) 62:5510-6.
42. Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, Sheehy ME, Ortiz GM, Ogg GS, et al. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma. AIDS Res Hum Retroviruses (2006) 22:52-6. doi:10.1089/aid.2006.22.52
43. Mullins C, Linnebacher M. Endogenous retrovirus sequences as a novel class of tumor-specific antigens: an example of HERV-H env encoding strong CTL epitopes. Cancer Immunol Immunother (2012) 61:1093-100. doi:10.1007/s00262-011-1183-3